Moreover, a recent study has demonstrated a compelling link between α‐synuclein aggregation in the CSF of PD patients and LRRK2 mutations, highlighting the role of genetic risk factors in disease pathogenesis (Cao et al. 2023). The gene discussed is LRRK2; the disease is Parkinson disease.